Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Autoimmune hepatitis is a chronic—or long lasting—disease in which the body’s immune system attacks the normal components, or cells, of the liver and causes inflammation and liver damage. The immune system normally protects people from infection by identifying and destroying bacteria, viruses, and other potentially harmful foreign substances. It is a serious condition that may worsen over time if not treated. Autoimmune hepatitis can lead to cirrhosis and liver failure. Cirrhosis occurs when scar tissue replaces healthy liver tissue and blocks the normal flow of blood through the liver. Liver failure occurs when the liver stops working properly. A combination of autoimmunity, environmental triggers, and a genetic predisposition can lead to autoimmune hepatitis. It is more common in females. The disease can occur at any age and affects all ethnic groups. Lifestyle Medicine, Personalized Medicine Diabetes and Translational Medicine are techniques used to analyze biological markers in the genome and proteome, realizing the value of personalized medicine the individual's genetic code and how their cells express their genes as proteins, by applying molecular biology to medical testing.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
A health care provider will make a diagnosis of autoimmune hepatitis based on symptoms, a physical exam, blood tests, and a liver biopsy. A health care provider performs a physical exam and reviews the person’s health history, including the use of alcohol and medications that can harm the liver. A person usually needs blood tests for an exact diagnosis because a person with autoimmune hepatitis can have the same symptoms as those of other liver diseases or metabolic disorders. People with autoimmune hepatitis who have no symptoms or a mild form of the disease may or may not need to take medication. A health care provider will determine if a person needs treatment. In some people with mild autoimmune hepatitis, the disease may go into remission. Remission is a period when a person is symptom-free and blood tests and liver biopsy show improvement in liver function.
For more than 3 decades, corticosteroids, either alone or in combination with azathioprine, have been the mainstays of drug therapy for patients with autoimmune hepatitis. The American Association for the Study of Liver Diseases (AASLD) and the British Society of Gastroenterology (BSG) recommend combination therapy, using the corticosteroid prednisone with azathioprine.
Physicians frustrated with treating patients who are sick instead of helping them stay well are turning toward preventive and lifestyle medicine techniques. However, a new practice philosophy can be risky, possibly costing patients and dollars. Experts say that with the right strategy, practices that invest in lifestyle medicine now are at the forefront of the next big change in healthcare. In 2007, John Principe, MD, was close to quitting medicine after 20 years of practicing primary care medicine in Palos Heights, Illinois. He was losing his passion for healthcare, but gaining an interest in cooking. He decided to attend the Harvard Healthy Kitchen’s Healthy Lives Program, and realized that lifestyle medicine was the answer to aligning his business with his new interests. The transition has not been an easy one, however.
International symposium and workshops:
1. Genomics and Personalized Medicine
February 7-11, 2016, Canada
2. Genomics in Medicine
February 19-20, 2015, USA
3. Symposium: Personalized Cancer Medicine
June 29 - 30, 2015, France
4. JIM Symposium in Personalized Medicine
August 5, Sweden
September 22-24, 2016 Berlin, Germany
November 28-30, 2016 Chicago, USA
November 17-19, 2016 San Francisco, USA
April 25-27, 2016 Valencia, Spain
October 31- November 02, 2016 Valencia, Spain
September 12-14, 2016 Berlin, Germany
July 18-20, 2016 Berlin, Germany
October 13-15, 2016 Dubai, UAE
9. 10th Biotech Congress
July 25-27, 2016 Bangkok, Thailand
October 10-12, 2016 Dubai, UAE
11. 4th Plant Genomics Conference
July 14-15, 2016 Brisbane, Australia
12. Personalized Medicine World Congress
January 24-27, Silicon Valley
13. Realizing Personalized Medicine through Integrative Medicine, Science and Technology
July 10-15, 2016
Relevant Society and Associations
1. The European Personalized Medicine Association
3. European Alliance for Personalized Medicine
4. Biotechnology Industry Organization
5. American Medical Association
6. Society of general Internal medicine
7. International society of internal medicine
8. Canadian society of internal medicine
9. Internal medicine professional societies
10. Cornell internal medicine associates
11. Wake internal medicine associates
1. Fierce Biotech
3. PM coalition
5. Chapel Hill Internal Medicine
6. Erland Internal medicine
7. Comprehensive internal medicine
8. Dillon internal medicine
9. Annapolis internal medicine
This page will be updated regularly.
This page was last updated on February 18, 2020